Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoram Reiter

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
European Journal of Immunology|March 23, 2010
Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificityOryan Makler, Kfir Oved, Nir Netzer, et al.
Toxins|November 17, 2018
SS1P Immunotoxin Induces Markers of Immunogenic Cell Death and Enhances the Effect of the CTLA-4 Blockade in AE17M Mouse Mesothelioma TumorsYasmin Leshem, Emily M King, Ronit Mazor, et al.
Journal of Molecular Recognition : JMR|October 3, 2003
Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactionsCyril J Cohen, Galit Denkberg, Avital Lev, et al.
Molecular Cancer Therapeutics|April 9, 2015
Recruitment of Oligoclonal Viral-Specific T cells to Kill Human Tumor Cells Using Single-Chain Antibody-Peptide-HLA Fusion MoleculesRoy Noy, Maya Haus-Cohen, Kfir Oved, et al.
International Journal of Cancer|March 5, 2004
Disruption of P-glycoprotein anticancer drug efflux activity by a small recombinant single-chain Fv antibody fragment targeted to an extracellular epitopeMaya Haus-Cohen, Yehuda G Assaraf, Liat Binyamin, et al.
International Journal of Cancer|June 2, 2004
Targeting an extracellular epitope of the human multidrug resistance protein 1 (MRP1) in malignant cells with a novel recombinant single chain Fv antibodyLiat Binyamin, Yehuda G Assaraf, Maya Haus-Cohen, et al.
Life Science Alliance|November 4, 2024
Antigen-specific modulation of chronic experimental autoimmune encephalomyelitis in humanized mice by TCR-like antibody targeting autoreactive T-cell epitopeAlona Goor, Efrat Altman, Inbar Arman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodiesCyril J Cohen, Offra Sarig, Yoshihisa Yamano, et al.
International Journal of Cancer|October 27, 2006
Selective antibody-mediated targeting of class I MHC to EGFR-expressing tumor cells induces potent antitumor CTL activity in vitro and in vivoHila Novak, Roy Noy, Kfir Oved, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2002
Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificityGalit Denkberg, Cyril J Cohen, Avital Lev, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Immunology|March 23, 2010
Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificityOryan Makler, Kfir Oved, Nir Netzer, et al.
Toxins|November 17, 2018
SS1P Immunotoxin Induces Markers of Immunogenic Cell Death and Enhances the Effect of the CTLA-4 Blockade in AE17M Mouse Mesothelioma TumorsYasmin Leshem, Emily M King, Ronit Mazor, et al.
Journal of Molecular Recognition : JMR|October 3, 2003
Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactionsCyril J Cohen, Galit Denkberg, Avital Lev, et al.
Molecular Cancer Therapeutics|April 9, 2015
Recruitment of Oligoclonal Viral-Specific T cells to Kill Human Tumor Cells Using Single-Chain Antibody-Peptide-HLA Fusion MoleculesRoy Noy, Maya Haus-Cohen, Kfir Oved, et al.
International Journal of Cancer|March 5, 2004
Disruption of P-glycoprotein anticancer drug efflux activity by a small recombinant single-chain Fv antibody fragment targeted to an extracellular epitopeMaya Haus-Cohen, Yehuda G Assaraf, Liat Binyamin, et al.
International Journal of Cancer|June 2, 2004
Targeting an extracellular epitope of the human multidrug resistance protein 1 (MRP1) in malignant cells with a novel recombinant single chain Fv antibodyLiat Binyamin, Yehuda G Assaraf, Maya Haus-Cohen, et al.
Life Science Alliance|November 4, 2024
Antigen-specific modulation of chronic experimental autoimmune encephalomyelitis in humanized mice by TCR-like antibody targeting autoreactive T-cell epitopeAlona Goor, Efrat Altman, Inbar Arman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodiesCyril J Cohen, Offra Sarig, Yoshihisa Yamano, et al.
International Journal of Cancer|October 27, 2006
Selective antibody-mediated targeting of class I MHC to EGFR-expressing tumor cells induces potent antitumor CTL activity in vitro and in vivoHila Novak, Roy Noy, Kfir Oved, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2002
Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificityGalit Denkberg, Cyril J Cohen, Avital Lev, et al.
Pageof 8